These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19381123)

  • 1. Nonalcoholic fatty liver disease and its association with cardiovascular disease.
    Lizardi-Cervera J; Aguilar-Zapata D
    Ann Hepatol; 2009; 8 Suppl 1():S40-3. PubMed ID: 19381123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between non-alcoholic fatty liver disease and cardiovascular disease: a first message should pass.
    Picardi A; Vespasiani-Gentilucci U
    Am J Gastroenterol; 2008 Dec; 103(12):3036-8. PubMed ID: 18853984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population.
    Stepanova M; Younossi ZM
    Clin Gastroenterol Hepatol; 2012 Jun; 10(6):646-50. PubMed ID: 22245962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care?
    Oni ET; Agatston AS; Blaha MJ; Fialkow J; Cury R; Sposito A; Erbel R; Blankstein R; Feldman T; Al-Mallah MH; Santos RD; Budoff MJ; Nasir K
    Atherosclerosis; 2013 Oct; 230(2):258-67. PubMed ID: 24075754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease.
    Targher G; Arcaro G
    Atherosclerosis; 2007 Apr; 191(2):235-40. PubMed ID: 16970951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic fatty liver disease and cardiovascular disease: has the time come for cardiologists to be hepatologists?
    Ahmed MH; Barakat S; Almobarak AO
    J Obes; 2012; 2012():483135. PubMed ID: 23320150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-alcoholic fatty liver disease is associated with cardiovascular disease risk markers.
    Edens MA; Kuipers F; Stolk RP
    Obes Rev; 2009 Jul; 10(4):412-9. PubMed ID: 19413701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspective: nonalcoholic fatty liver disease and cardiovascular risk.
    Nestel PJ; Mensink RP
    Curr Opin Lipidol; 2013 Feb; 24(1):1-3. PubMed ID: 23298957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?
    Targher G; Marra F; Marchesini G
    Diabetologia; 2008 Nov; 51(11):1947-53. PubMed ID: 18762907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular and systemic risk in nonalcoholic fatty liver disease - atherosclerosis as a major player in the natural course of NAFLD.
    Lonardo A; Sookoian S; Chonchol M; Loria P; Targher G
    Curr Pharm Des; 2013; 19(29):5177-92. PubMed ID: 23432668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular disease and nonalcoholic fatty liver disease: does histologic severity matter?
    Domanski JP; Park SJ; Harrison SA
    J Clin Gastroenterol; 2012; 46(5):427-30. PubMed ID: 22469639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cardiovascular link to nonalcoholic fatty liver disease: a critical analysis.
    Pacana T; Fuchs M
    Clin Liver Dis; 2012 Aug; 16(3):599-613. PubMed ID: 22824483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of cardiovascular disease and chronic kidney disease in diabetic patients with non-alcoholic fatty liver disease: just a coincidence?
    Targher G; Chonchol M; Pichiri I; Zoppini G
    J Endocrinol Invest; 2011; 34(7):544-51. PubMed ID: 21427524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease.
    Luo J; Xu L; Li J; Zhao S
    Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):193-9. PubMed ID: 25563143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.
    Athyros VG; Alexandrides TK; Bilianou H; Cholongitas E; Doumas M; Ganotakis ES; Goudevenos J; Elisaf MS; Germanidis G; Giouleme O; Karagiannis A; Karvounis C; Katsiki N; Kotsis V; Kountouras J; Liberopoulos E; Pitsavos C; Polyzos S; Rallidis LS; Richter D; Tsapas AG; Tselepis AD; Tsioufis K; Tziomalos K; Tzotzas T; Vasiliadis TG; Vlachopoulos C; Mikhailidis DP; Mantzoros C
    Metabolism; 2017 Jun; 71():17-32. PubMed ID: 28521870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic Fatty Liver Disease and the Heart: JACC State-of-the-Art Review.
    Stahl EP; Dhindsa DS; Lee SK; Sandesara PB; Chalasani NP; Sperling LS
    J Am Coll Cardiol; 2019 Mar; 73(8):948-963. PubMed ID: 30819364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic Fatty Liver Disease Pandemic Fuels the Upsurge in Cardiovascular Diseases.
    Cai J; Zhang XJ; Ji YX; Zhang P; She ZG; Li H
    Circ Res; 2020 Feb; 126(5):679-704. PubMed ID: 32105577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients.
    Targher G; Bertolini L; Padovani R; Rodella S; Tessari R; Zenari L; Day C; Arcaro G
    Diabetes Care; 2007 May; 30(5):1212-8. PubMed ID: 17277038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question.
    Loria P; Lonardo A; Bellentani S; Day CP; Marchesini G; Carulli N
    Nutr Metab Cardiovasc Dis; 2007 Nov; 17(9):684-98. PubMed ID: 17560098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic fatty liver disease (NAFLD): a new risk factor for adverse cardiovascular events in dialysis patients.
    Mikolasevic I; Racki S; Zaputovic L; Lukenda V; Milic S; Orlic L
    Med Hypotheses; 2014 Feb; 82(2):205-8. PubMed ID: 24365277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.